Skip to content

Author

A. Patsouris

We have 1 of 102 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Pembrolizumab plus anthracyclines in triple-negative breast cancer: prospective evaluation of early cardiac safety

Biomarker elevations were common but rarely translated into functional cardiac impairment, supporting the short-term cardiac safety of pembrolizumab when managed within a structured cardio-oncology surveillance program.

A. Besnard, A. Patsouris, L. Bière et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.